Clinical Trial

Relationship About Pregnancy Health and Offspring Developmental &Behavioral Outcomes

Study acronym: APCSAHAODBO
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 1, 2021 (before its estimated July 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This topic puts forward a hypothesis: genetic and environmental factors such as major depressive disorder during pregnancy, nutritional status of vitamin A, D, E, and folic acid, intestinal microecology, and bisphenol A exposure, may affect the cognitive development level of the offspring through the genetic correlation with attention deficit hyperactivity disorder, developmental delay/intellectual disability, and major depressive disorder, allelic heterogeneity and pleiotropy of ITIH3 mediated by SNP and CACNB2, neurotransmitters like dopamine, and metabolic pathways, thereby increasing the risk of attention deficit hyperactivity disorder and developmental delay/intellectual disability prevalence on offspring. This topic planning from allelic heterogeneity and pleiotropy of attention deficit hyperactivity disorder and major depressive disorder mediated by SNP, neurotransmitters like dopamine, and metabolic pathways, explores deeply the influences on children's development level and the risk of common neurological disorder caused by genetic and environmental factors during pregnancy, looking for reasonable prevention, early diagnosis of biomarkers and therapeutic targets, in order to provide data support for further improvement and revision of national mother and infant healthcare policy .
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2019-07-11; most recent amendment 2021-01-29.
Trial Details
NCT Number NCT04017286
Lead Sponsor Chen Li
Conditions Children Behavior Problem, Pregnancy
Enrollment 3,000 participants
Start Date 2019-07-01
Primary Completion 2025-07-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2021-02-01